|
|
PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, October 6 ... - Trading Markets (press release) |
|
Trading Markets (press release)Rockwell is a fully-integrated biopharmaceutical company offering innovative products and services initially targeting end-stage renal disease (ESRD), ... |
|
|
PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts ... - Trading Markets (press release) |
|
Trading Markets (press release)Rockwell is a fully-integrated biopharmaceutical company offering innovative products and services initially targeting end-stage renal disease (ESRD), ... |
|
Regorafenib shows a solid breakthrough in Renal Cancer - InjuryBoard.com (blog) |
|
InjuryBoard.com (blog)The findings are promising for renal cell carcinoma, the most common (about 90%) of all kidney cancers that challenge people in the 50 to 80 year old age ... |
|
FDA unanimously recommends GSK's kidney cancer treatment - Drug Store News (blog) |
|
Drug Store News (blog)... Committee had voted unanimously to recommend approval for Votrient (pazopanib), an investigational pill-based treatment for renal cell carcinoma. ...GlaxoSmithKline Gets FDA Panel Recommendation For Kidney Cancer ... |
|
Patient group sets up forum for dialogue on the ESRD bundled payment - NephrOnline |
|
NephrOnlineThe new payment system takes effect in 2011, and will reimburse all dialysis-related drugs and services in one bundled payment (that is, ... |
|
|
|
|
<< Start < Prev 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 Next > End >>
|
|
Page 1984 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
